{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:28:23Z","timestamp":1740126503921,"version":"3.37.3"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":581,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,17]]},"DOI":"10.1111\/cei.13431","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T07:30:29Z","timestamp":1584430229000},"page":"299-301","source":"Crossref","is-referenced-by-count":2,"title":["ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis"],"prefix":"10.1093","volume":"200","author":[{"given":"N","family":"Ettischer-Schmid","sequence":"first","affiliation":[{"name":"GenID GmbH, Strassberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6803-8588","authenticated-orcid":false,"given":"R","family":"Preyer","sequence":"additional","affiliation":[{"name":"GenID GmbH, Strassberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"key":"2021121023094660200_cei13431-bib-0001","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/cei.13393","article-title":"Prospective comparison of two enzyme-linked immunosorbent spot assays for the diagnosis of Lyme neuroborreliosis","volume":"199","author":"van Gorkom","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"2021121023094660200_cei13431-bib-0002","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol"},{"key":"2021121023094660200_cei13431-bib-0003","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.43.1_Part_1.169","article-title":"Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study","volume":"43","author":"Hammers-Berggren","year":"1993","journal-title":"Neurology"},{"key":"2021121023094660200_cei13431-bib-0004","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1212\/01.wnl.0000269672.17807.e0","article-title":"Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients","volume":"69","author":"Blanc","year":"2007","journal-title":"Neurology"},{"key":"2021121023094660200_cei13431-bib-0005","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/JCM.00084-11","article-title":"Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid","volume":"49","author":"van Burgel","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2021121023094660200_cei13431-bib-0006","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jim.2004.06.008","article-title":"Evaluation of Elispot assays: influence of method and operator on variability of results","volume":"291","author":"Janetzki","year":"2004","journal-title":"J Immunol Methods"},{"key":"2021121023094660200_cei13431-bib-0007","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1086\/382893","article-title":"Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome","volume":"189","author":"Widhe","year":"2004","journal-title":"J Infect Dis"},{"key":"2021121023094660200_cei13431-bib-0008","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-3083.1995.tb03713.x","article-title":"Lyme neuroborreliosis: evidence for persistent up-regulation of Borrelia burgdorferi-reactive cells secreting interferon-gamma","volume":"42","author":"Wang","year":"1995","journal-title":"Scand J Immunol"},{"key":"2021121023094660200_cei13431-bib-0009","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/cells3041102","article-title":"Stepping up ELISpot: multi-level analysis in fluorospot assays","volume":"3","author":"Janetzki","year":"2014","journal-title":"Cells"},{"key":"2021121023094660200_cei13431-bib-0010","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1111\/ajt.12285","article-title":"Cross-validation of IFN-gamma Elispot assay for measuring alloreactive memory\/effector T cell responses in renal transplant recipients","volume":"13","author":"Bestard","year":"2013","journal-title":"Am J Transplant"},{"key":"2021121023094660200_cei13431-bib-0011","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ki.2013.236","article-title":"Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation","volume":"84","author":"Bestard","year":"2013","journal-title":"Kidney Int"},{"key":"2021121023094660200_cei13431-bib-0012","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000365816","article-title":"Bifunctional T-cell-derived cytokines for the diagnosis of tuberculosis and treatment monitoring","volume":"88","author":"Essone","year":"2014","journal-title":"Respiration"},{"key":"2021121023094660200_cei13431-bib-0013","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/archderm.1970.04000070106017","article-title":"Erythema chronicum migrans","volume":"102","author":"Scrimenti","year":"1970","journal-title":"Arch Dermatol"},{"key":"2021121023094660200_cei13431-bib-0014","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3201\/eid2109.150417","article-title":"Incidence of clinician-diagnosed Lyme disease, United States, 2005\u20132010","volume":"21","author":"Nelson","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2021121023094660200_cei13431-bib-0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cll.2015.08.004","article-title":"Clinical manifestations and treatment of Lyme disease","volume":"35","author":"Sanchez","year":"2015","journal-title":"Clin Lab Med"},{"key":"2021121023094660200_cei13431-bib-0016","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2249.1995.tb03134.x","article-title":"The outer surface proteins of Lyme disease borrelia spirochetes stimulate T cells to secrete interferon-gamma (IFN-gamma): diagnostic and pathogenic implications","volume":"101","author":"Forsberg","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"2021121023094660200_cei13431-bib-0017","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/00365549309008548","article-title":"Clinical manifestations and antibody prevalence of Lyme borreliosis and tick-borne encephalitis in Sweden: a study in five endemic areas close to Stockholm","volume":"25","author":"Gustafson","year":"1993","journal-title":"Scand J Infect Dis"},{"key":"2021121023094660200_cei13431-bib-0018","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/cid\/ciw112","article-title":"Detection of IFN-\u03b3 secretion by T cells collected before and after successful treatment of early Lyme disease","volume":"62","author":"Callister","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2021121023094660200_cei13431-bib-0019","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2249.2005.02993.x","article-title":"Reduced number of interleukin-12 secreting cells in patients with Lyme borreliosis previously exposed to Anaplasma phagocytophilum","volume":"143","author":"Jarefors","year":"2006","journal-title":"Clin Exp Immunol"},{"volume-title":"Neues Verfahren zum verbesserten Nachweis Antigen-spezifischer Immunzellen in extrasanguinen Fl\u00fcssigkeiten","year":"2015","author":"Schub","key":"2021121023094660200_cei13431-bib-0020"},{"key":"2021121023094660200_cei13431-bib-0021","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1186\/s12879-019-4323-6","article-title":"Validation of cellular tests for Lyme borreliosis (VICTORY) study","volume":"19","author":"van de Schoor","year":"2019","journal-title":"BMC Infect Dis"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.13431","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.13431","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.13431","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/200\/3\/299\/41638724\/cei13431.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/200\/3\/299\/41638724\/cei13431.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:28:15Z","timestamp":1641054495000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/200\/3\/299\/6378145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,4,14]]},"published-print":{"date-parts":[[2020,5,17]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13431","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"type":"print","value":"0009-9104"},{"type":"electronic","value":"1365-2249"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2020,4,14]]}}}